Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)

Histopathology

Volumn 59, Issue 4, 2011, Pages 751-762

  Gosney, John R ^a   Williams, Ian J ^a   Dodson, Andrew R ^a   Foster, Christopher S ^b  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

DIPNECH; Proliferation; Pulmonary neuroendocrine cells

Indexed keywords

CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CHROMOGRANIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN; GASTRIN RELEASING PEPTIDE; GENE PRODUCT; NERVE CELL ADHESION MOLECULE; NEURON SPECIFIC ENOLASE; PROTEIN BCL 2; PROTEIN KI67; PROTEIN P16; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CARCINOID; CELL DEATH; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL ARTICLE; DIFFUSE IDIOPATHIC PULMONARY NEUROENDOCRINE CELL HYPERPLASIA; FEMALE; GENE PRODUCT 9.5; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG INJURY; MALE; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS; CELL PROLIFERATION; FEMALE; HUMANS; HYPERPLASIA; LUNG DISEASES; LUNG INJURY; MALE; MIDDLE AGED; NEUROENDOCRINE CELLS; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054925045     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03992.x     Document Type: Article

References (24)

1. Gosney JR. Pulmonary endocrine pathology: endocrine cells and endocrine tumours of the lung. Oxford: Butterworth-Heinemann, 1992.
2. Sunday ME. Pulmonary neuroendocrine cells and lung development. Endocr. Pathol. 1996; 7; 173-201.
3. Linnoila RI. Functional facets of the pulmonary neuroendocrine system. Lab. Invest. 2006; 86; 425-444.
4. Travis WD. The concept of pulmonary neuroendocrine tumours. In Travis WD, Brambilla E, Muller-Hermelink H-K, Harris CC eds. Pathology and genetic. Tumours of the lung, pleura, thymus and heart. Lyons: IARC Press, 2004; 19-20.
5. Aguayo SM, Miller YE, Waldron JA et al. Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N. Engl. J. Med. 1992; 327; 1285-1288.
6. Armas OA, White DA, Erlandson RA, Rosai J. Diffuse idiopathic neuroendocrine cell proliferation presenting as interstitial lung disease. Am. J. Surg. Pathol. 1995; 19; 963-970.
7. Miller RR, Muller LL. Neuroendocrine cell hyperplasia and obliterative bronchiolitis in patients with peripheral carcinoid tumours. Am. J. Surg. Pathol. 1995; 19; 653-658.
8. Davies SJ, Gosney JR, Hansell DM et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007; 62; 248-252.
9. Gosney JR, Travis WD. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. In Travis WD, Brambilla E, Muller-Hermelink H-K, Harris CC eds. Pathology and genetics. Tumours of the lung, pleura, thymus and hear. Lyons: IARC Press, 2004; 76-77.
10. Gould VE, Linnoila RI, Memoli VA, Warren WH. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms. Lab. Invest. 1983; 49; 519-537.
11. Barbareschi M, Girlando S, Mauri FA et al. Tumour suppressor gene products, proliferation and differentiation markers in lung neuroendocrine neoplasms. J. Pathol. 1992; 166; 343-350.
12. Brambilla E, Negoescu A, Gazzeri S et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumours. Am. J. Pathol. 1996; 149; 1941-1952.
13. Folpe AL, Gown MD, Lamps LW et al. Thyroid transcription factor 1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod. Pathol. 2004; 12; 508.
14. Pelosi G, Mausullo M, Leon ME et al. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas. Virchows Arch. 2004; 445; 449-455.
15. Sturm N, Rossi G, Lantuejoul S et al. 34βE12 expression along the whole spectrum of neuroendocrine proliferations of the lung from neuroendocrine hyperplasia to small cell carcinoma. Histopathology 2003; 42; 156-166.
16. Marson J, Mazieres J, Groussard O et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 2004; 45; 125-134.
17. Cohen AJ, Bunn PA, Franklin W et al. Neural endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux. Cancer Res. 1996; 56; 831-839.
18. Beasley MB, Lantuejoul S, Abbondanzo S et al. The p16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Hum. Pathol. 2003; 34; 136-142.
19. Lloyd RV, Jin L, Qian X, Kulig E. Aberrant p27kip1 expression in endocrine and other tumours. Am. J. Pathol. 1997; 150; 401-407.
20. Sturm N, Rossi G, Lantuejoul S et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum. Pathol. 2002; 33; 175-182.
21. Du EZ, Goldstraw P, Zacharias J et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1 positive carcinoids are predominantly in peripheral location. Hum. Pathol. 2004; 35; 825-831.
22. Gosney JR, Green ART, Taylor W. Appropriate and inappropriate neuroendocrine products in pulmonary tumourlets. Thorax 1990; 45; 679-683.
23. Theile A, Muller KM. Proliferation kinetics of bronchioloalveolar tumorlets. Pathologie 1996; 17; 163-170.
24. Finkelstein SD, Hasegawa T, Colby T, Yousem SA. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. Am. J. Pathol. 1999; 155; 633-640.